Cybersecurity by Design: The Three Pillars Behind Secure Pharma Manufacturing

As machines, MES, and customer networks become increasingly connected, cybersecurity in pharmaceutical manufacturing is no longer optional. Protecting production data requires more than generic security claims. It demands a structured approach built into the architecture of the equipment and systems themselves.

At Dara Pharma, cybersecurity is based on three fundamental pillars: Confidentiality, Integrity, and Availability.

Confidentiality

Ensuring that sensitive production and process data can only be accessed by authorized users is a key cybersecurity requirement in modern pharmaceutical environments.

To support confidentiality, Dara Pharma implements:

• Network segmentation between machine and customer networks.
• Industrial-grade firewalls installed directly on the equipment.
• Role-based access control, ensuring that only authorized users can view or modify sensitive process data.

Integrity

Maintaining the accuracy, reliability, and traceability of production and quality data is essential in regulated pharmaceutical manufacturing.

Dara Pharma addresses integrity through:

• Native 21 CFR Part 11 compliance.
• Audit trails, electronic signatures, and access controls that help keep production and quality data accurate and tamper-evident.
• Isolated networks for each production line, preventing cross-contamination and unauthorized configuration changes.

Availability

Security measures must coexist with operational performance. In pharmaceutical production environments, maintaining uptime and throughput is critical.

To support availability, Dara Pharma incorporates:

• Security controls designed not to compromise production continuity, particularly in continuous aseptic manufacturing processes.
• Controlled and secure data export mechanisms that allow information to flow to customer systems without exposing equipment to external risks.

Looking Ahead

Dara Pharma is currently working toward ISO/IEC 27001 certification for its information security management system and advancing its alignment with the European Union's NIS2 Directive.

This work is being guided by Spain's National Security Framework (ENS) as the implementation reference and complemented by IEC 62443 principles for industrial control systems.

Security by Design at Every Layer

For Dara Pharma, security by design is not a slogan. It is an architectural decision applied throughout the entire system, from the firewall integrated into the machine to the infrastructure that supports it.

By addressing confidentiality, integrity, and availability at every level, cybersecurity becomes an integral part of pharmaceutical manufacturing operations rather than an afterthought.